GlassScriptPhysician profile
Raza A Khan
NPI 1407067929
$12,278.83
in general payments reported to CMS, 2019-2025
15 companies · $2,323 in 2025
The $2,323 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $464 · 2021: $497 · 2022: $375 · 2023: $976 · 2024: $7,132 · 2025: $2,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,236 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,350 · Travel and Lodging: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,236.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,350.00 |
| Travel and Lodging | $844.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,132.53 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $4,941.62 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Pain Management |
| Medtronic, INC. | $526.04 | 2023-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Stimwave Technologies Incorporated | $175.78 | 2019 | |
| Medtronic USA, INC. | $120.01 | 2019 | |
| Spr Therapeutics, INC | $99.30 | 2020-2025 | Sprint Pns System |
| Forte Bio-Pharma LLC | $72.57 | 2025 | Prolate, Nalocet, Tanlor |
| Dentsply Ih INC. | $41.43 | 2023 | Lofric |
| Curonix LLC | $36.13 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $31.39 | 2024 | Senza |
| Vertex Pharmaceuticals Incorporated | $29.52 | 2025 | |
| Abbvie INC. | $26.86 | 2025 | |
| Nalu Medical, INC. | $21.24 | 2022 | |
| Globus Medical, INC. | $15.84 | 2025 | Senza |
| Mml US, INC. | $8.57 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raza Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.